Randox is committed to improving health worldwide with the firm belief that the healthcare of tomorrow depends on innovations developed today. Our passion for innovation, creativity and investment in R&D enables us to continually develop our products and evolve for the future. As a world leader in the in-vitro diagnostics industry, Randox is committed to developing revolutionary diagnostic products designed to improve health globally including chemistry, immunoassay, molecular & POC analysers in addition to high quality reagents. Leading provider of complete quality control solutions including; daily quality control, calibration verification and proficiency testing for results you can trust. Biochip Array Technology is a unique multiplexing method offering clinical, research and molecular panels. We also offer a range of COVID-19 testing solutions for all testing needs. Randox is leading the change in moving from a one-size-fits-all approach towards decisions and products tailored to the needs of the individual.
